AU Patent

AU2023412900A1 — Eye drop-type pharmaceutical composition containing envogliflozin

Assigned to Daewoong Therapeutics Inc · Expires 2025-06-12 · 1y expired

What this patent protects

Patent listed against sulfur-hexafluoride-lipid-type-a-microspheres.

Drugs covered by this patent

sulfur-hexafluoride-lipid-type-a-microspheres (Sulfur hexafluoride lipid-type A microspheres) · Children's Hospital of Philadelphia

Patent Metadata

Patent number: AU2023412900A1
Jurisdiction: AU
Classification: —
Expires: 2025-06-12
Drug substance claim: No
Drug product claim: No
Assignee: Daewoong Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.